103 related articles for article (PubMed ID: 12296648)
1. Aberrant G protein signaling in nervous system tumors.
Woods SA; Marmor E; Feldkamp M; Lau N; Apicelli AJ; Boss G; Gutmann DH; Guha A
J Neurosurg; 2002 Sep; 97(3):627-42. PubMed ID: 12296648
[TBL] [Abstract][Full Text] [Related]
2. Rap1 activity is elevated in malignant astrocytomas independent of tuberous sclerosis complex-2 gene expression.
Lau N; Uhlmann EJ; Von Lintig FC; Nagy A; Boss GR; Gutmann DH; Guha A
Int J Oncol; 2003 Jan; 22(1):195-200. PubMed ID: 12469204
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas.
Jozwiak J; Kotulska K; Grajkowska W; Jozwiak S; Zalewski W; Oldak M; Lojek M; Rainko K; Maksym R; Lazarczyk M; Skopinski P; Wlodarski P
Brain Dev; 2007 Jun; 29(5):273-80. PubMed ID: 17071037
[TBL] [Abstract][Full Text] [Related]
4. Ras activation in astrocytomas and neurofibromas.
Guha A
Can J Neurol Sci; 1998 Nov; 25(4):267-81. PubMed ID: 9827227
[TBL] [Abstract][Full Text] [Related]
5. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
[TBL] [Abstract][Full Text] [Related]
6. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
[TBL] [Abstract][Full Text] [Related]
7. Alterations in the rap1 signaling pathway are common in human gliomas.
Gutmann DH; Saporito-Irwin S; DeClue JE; Wienecke R; Guha A
Oncogene; 1997 Sep; 15(13):1611-6. PubMed ID: 9380414
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a novel malignant astrocytoma cell line derived from a tumor removed in a patient with neurofibromatosis type 1.
Kurimoto M; Hirashima Y; Ogiichi T; Hamada H; Kamiyama H; Endo S
J Neurosurg; 2001 Feb; 94(2):301-8. PubMed ID: 11213969
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 peripheral nerve tumors: aberrant activation of the Ras pathway.
Feldkamp MM; Angelov L; Guha A
Surg Neurol; 1999 Feb; 51(2):211-8. PubMed ID: 10029430
[TBL] [Abstract][Full Text] [Related]
10. The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey.
Skalicky AM; Rentz AM; Liu Z; Wheless JW; Pelletier CL; Dunn DW; Frost MD; Nakagawa J; Magestro M; Prestifilippo J; Pashos C
J Child Neurol; 2015 Apr; 30(5):563-9. PubMed ID: 24667738
[TBL] [Abstract][Full Text] [Related]
11. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
[TBL] [Abstract][Full Text] [Related]
12. Role of the Rap1 GTPase in astrocyte growth regulation.
Apicelli AJ; Uhlmann EJ; Baldwin RL; Ding H; Nagy A; Guha A; Gutmann DH
Glia; 2003 May; 42(3):225-34. PubMed ID: 12673829
[TBL] [Abstract][Full Text] [Related]
13. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
[TBL] [Abstract][Full Text] [Related]
14. RAS/MEK-independent gene expression reveals BMP2-related malignant phenotypes in the Nf1-deficient MPNST.
Sun D; Haddad R; Kraniak JM; Horne SD; Tainsky MA
Mol Cancer Res; 2013 Jun; 11(6):616-27. PubMed ID: 23423222
[TBL] [Abstract][Full Text] [Related]
15. Role of GTPases and GTPase regulatory proteins in oncogenesis.
Grunicke HH; Maly K
Crit Rev Oncog; 1993; 4(4):389-402. PubMed ID: 8353139
[TBL] [Abstract][Full Text] [Related]
16. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
Su W; Xing R; Guha A; Gutmann DH; Sherman LS
Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
[TBL] [Abstract][Full Text] [Related]
17. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors.
Guha A; Lau N; Huvar I; Gutmann D; Provias J; Pawson T; Boss G
Oncogene; 1996 Feb; 12(3):507-13. PubMed ID: 8637706
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells.
Mangoura D; Sun Y; Li C; Singh D; Gutmann DH; Flores A; Ahmed M; Vallianatos G
Oncogene; 2006 Feb; 25(5):735-45. PubMed ID: 16314845
[TBL] [Abstract][Full Text] [Related]
20. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
